ECSP024362A - REPLACED 1-AMINOALQUIL-LACTAMAS AND ITS USE AS ANTAGONIST OF MUSCARINIC RECEPTORS - Google Patents
REPLACED 1-AMINOALQUIL-LACTAMAS AND ITS USE AS ANTAGONIST OF MUSCARINIC RECEPTORSInfo
- Publication number
- ECSP024362A ECSP024362A EC2002004362A ECSP024362A ECSP024362A EC SP024362 A ECSP024362 A EC SP024362A EC 2002004362 A EC2002004362 A EC 2002004362A EC SP024362 A ECSP024362 A EC SP024362A EC SP024362 A ECSP024362 A EC SP024362A
- Authority
- EC
- Ecuador
- Prior art keywords
- muscarinic receptors
- aminoalquil
- lactamas
- antagonist
- replaced
- Prior art date
Links
- 102000014415 Muscarinic acetylcholine receptor Human genes 0.000 title abstract 2
- 108050003473 Muscarinic acetylcholine receptor Proteins 0.000 title abstract 2
- 239000005557 antagonist Substances 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000005856 abnormality Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 210000002460 smooth muscle Anatomy 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Esta invención se refiere a compuestos que son generalmente antagonistas de los receptores muscarínicos M2/M3 y que están generalmente por la fórmula en donde X;Y y Z son O2, S, o N-R5 y los otros sustituyentes tal como se definen en la especificación; o pro fármacos, isomeros individuales, mezclas racemicas o no-racemicas de isomeros, y sales o solvatos farmacéuticamente aceptables de log mismos. La invención además se refiere a las composiciones farmacéuticas que contienen dichos compuestos. Los procesos para su preparación y su utilidad para el tratamiento de enfermedades asociadas con anomalías en el músculo liso.This invention relates to compounds that are generally antagonists of M2 / M3 muscarinic receptors and that are generally by the formula wherein X; Y and Z are O2, S, or N-R5 and the other substituents as defined in specification; or pro drugs, individual isomers, racemic or non-racemic mixtures of isomers, and pharmaceutically acceptable salts or solvates of the same log. The invention also relates to pharmaceutical compositions containing said compounds. The processes for its preparation and its usefulness for the treatment of diseases associated with abnormalities in smooth muscle.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20748300P | 2000-05-25 | 2000-05-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP024362A true ECSP024362A (en) | 2003-03-31 |
Family
ID=32849292
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2002004363A ECSP024363A (en) | 2000-05-25 | 2002-11-25 | REPLACED 1-AMINOALQUIL-LACTAMAS AND ITS USE AS ANTAGONIST OF MUSCARINIC RECEPTORS |
| EC2002004362A ECSP024362A (en) | 2000-05-25 | 2002-11-25 | REPLACED 1-AMINOALQUIL-LACTAMAS AND ITS USE AS ANTAGONIST OF MUSCARINIC RECEPTORS |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2002004363A ECSP024363A (en) | 2000-05-25 | 2002-11-25 | REPLACED 1-AMINOALQUIL-LACTAMAS AND ITS USE AS ANTAGONIST OF MUSCARINIC RECEPTORS |
Country Status (2)
| Country | Link |
|---|---|
| EC (2) | ECSP024363A (en) |
| ZA (2) | ZA200208895B (en) |
-
2002
- 2002-11-01 ZA ZA200208895A patent/ZA200208895B/en unknown
- 2002-11-06 ZA ZA200209029A patent/ZA200209029B/en unknown
- 2002-11-25 EC EC2002004363A patent/ECSP024363A/en unknown
- 2002-11-25 EC EC2002004362A patent/ECSP024362A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200208895B (en) | 2004-02-19 |
| ZA200209029B (en) | 2004-02-06 |
| ECSP024363A (en) | 2003-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY26729A1 (en) | HETEROCYCLIC ALKYLAMINES AS ANTAGONISTS OF MUSCARINIC RECEPTORS | |
| UY27336A1 (en) | 4-PIPERACINYLINDOL DERIVATIVES WITH 5-HT6 RECEPTOR AFFINITY | |
| ECSP045519A (en) | NEW DERIVATIVES OF QUINUCLIDINA-AMIDA | |
| UY29825A1 (en) | SUBSTITUTED DERIVATIVES OF 3H-IMIDAZOL- (4.5 B (BETA)) PIRIDINA-2-IL BENZOATES AND BENZAMIDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND APPLICATIONS | |
| UY28026A1 (en) | 4-PIPERAZINILBENCENOSULFONILINDOLES AND USES OF THE SAME. | |
| AR029463A1 (en) | DISPOSED PIRROLIDINS, A PROCESS FOR PREPARATION, PHARMACEUTICAL COMPOSITIONS AND THE USE OF SUCH COMPOUNDS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT | |
| UY27322A1 (en) | NEW INDOL DERIVATIVES WITH AFFINITY FOR THE 5-HT6 RECEIVER | |
| AR033377A1 (en) | DERIVATIVES OF BENZOCICLOALQUILENILAMINA AS ANTAGONISTS OF MUSCARINIC RECEPTORS | |
| PA8587101A1 (en) | NEW DERIVATIVES OF DIHYDROPIRIMIDO [4,5-D] PIRIMIDINONE REPLACED BY AMIINO, MANUFACTURE AND USE OF THE SAME AS PHARMACEUTICAL AGENTS | |
| PA8591701A1 (en) | PIRROLOPIRIMIDINE DERIVATIVES | |
| PA8580301A1 (en) | NEW BENZOIMIDAZOL DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS | |
| UY27109A1 (en) | DERIVATIVES OF QUINAZOLONA AS ANTAGONISTS OF ADRENERGIC RECEPTORS ALFA-1A / B | |
| BR0307406A (en) | Indols Replaced as Alpha-1 Agonists | |
| CR9834A (en) | [1,8] NAFTIRIDIN-2-ONAS AND RELATED COMPOUNDS FOR THE TREATMENT OF EZQUIZOPHRENIA | |
| PA8623001A1 (en) | SUBSTITUTED QUINOLINE COMPOUNDS | |
| ECSP055671A (en) | NEW ESPIROCONDENSED QUINAZOLINONES AND ITS USE AS PHOSPHODESTERESA INHIBITORS | |
| UY28150A1 (en) | THERAPEUTIC AGENTS | |
| SG147466A1 (en) | Thrombin receptor antagonists | |
| UY28105A1 (en) | INDAZOL DERIVATIVES AS CRF ANTAGONISTS | |
| ECSP099394A (en) | DERIVATIVES OF QUINUCLIDINOL AS ANTOGONISTS OF MUSCARINIC RECEPTORS | |
| ECSP088967A (en) | MUSCARINIC RECEIVER AGONISTS THAT ARE EFFECTIVE IN THE TREATMENT OF PAIN, ALZHEIMER'S DISEASE AND SCHIZOPHRENIA | |
| GT200600163A (en) | NEW THERAPEUTIC COMBINATIONS FOR THE TREATMENT OR PREVENTION OF DEPRESSION | |
| UY27786A1 (en) | ISOQUINOLINE DERIVATIVES. | |
| PA8568101A1 (en) | INDOLIL-UREA DERIVED FROM USEFUL TIENOPIRIDINS AS ANTIANGIOGEN AGENTS, AND PROCEDURES FOR USE | |
| PA8540601A1 (en) | DERIVATIVES OF ALCOXICARBONILAMINOTETRAZOLIL PHENYLL OR BENZOIC ALCOXICARBONYLAMINE ACID AS IP ANTAGONISTS |